This could lead to health issues of its own
Astrocyte-microglia crosstalk: a novel target for the treatment of migraine
Robert Kushner, a principal investigator on multiple STEP trials, stated in a 2023 JAMA editorial: "The cost barrier remains the single largest impediment to appropriate utilization of GLP-1 receptor agonists for obesity, particularly in states without Medicaid coverage mandates" 27
Ninety percent of the AIA-positive patients on TOUJEO with antibody test at baseline, remained AIA positive at month 6
Contact your GP or diabetes specialist promptly if you experience severe persistent vomiting or diarrhoea, severe abdominal pain (particularly radiating to the back), signs of hypoglycaemia, symptoms of gallbladder problems, vision changes, or unexplained persistent nausea beyond the first few weeks